US Stock MarketDetailed Quotes

DSGN Design Therapeutics

Watchlist

6.490
+0.140+2.20%

Close Dec 26 16:00 ET

5.610
-0.880-13.56%

Pre 07:14 ET

367.47MMarket Cap-7.64P/E (TTM)

Design Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-12.67%254.07M

-13.88%261.02M

-14.17%270.69M

-14.71%281.8M

-15.48%290.94M

-15.66%303.09M

-15.04%315.39M

-13.98%330.39M

-Cash and cash equivalents

8.54%30.33M

68.03%45.7M

2.04%29.4M

-20.00%21.2M

-34.28%27.94M

-77.27%27.2M

-89.97%28.81M

-91.12%26.5M

-Short-term investments

-14.92%223.75M

-21.96%215.32M

-15.80%241.29M

-14.25%260.6M

-12.83%263M

15.09%275.89M

241.54%286.58M

255.44%303.89M

Receivables

-2.40%1.18M

40.64%1.4M

72.07%1.68M

28.43%1.43M

61.93%1.21M

43.85%994K

874.00%974K

913.64%1.12M

-Accrued interest receivable

-2.40%1.18M

40.64%1.4M

72.07%1.68M

28.43%1.43M

61.93%1.21M

43.85%994K

874.00%974K

913.64%1.12M

Prepaid assets

-16.95%1.99M

23.69%2.43M

-40.77%1.52M

-62.57%1.35M

-31.75%2.4M

38.43%1.96M

5.49%2.57M

186.84%3.62M

Total current assets

-12.66%257.24M

-13.46%264.84M

-14.13%273.89M

-15.08%284.58M

-15.48%294.54M

-15.39%306.05M

-14.69%318.94M

-13.05%335.12M

Non current assets

Net PPE

-19.00%3.96M

-16.14%4.31M

-16.29%4.48M

-16.73%4.63M

-12.93%4.89M

-10.37%5.14M

8.56%5.35M

8.53%5.56M

-Gross PPE

-5.92%5.47M

-4.41%5.66M

-5.35%5.68M

-6.46%5.69M

-3.38%5.81M

-1.68%5.93M

17.09%6M

15.70%6.08M

-Accumulated depreciation

-63.52%-1.51M

-72.58%-1.35M

-84.64%-1.2M

-102.87%-1.06M

-131.41%-921K

-170.34%-784K

-230.46%-651K

-289.55%-522K

Other non current assets

-2.29%427K

-3.38%429K

-5.53%427K

-6.32%430K

-6.22%437K

-6.33%444K

--452K

--459K

Total non current assets

-17.63%4.39M

-15.13%4.74M

-15.45%4.91M

-15.94%5.06M

-12.42%5.33M

-10.06%5.59M

17.73%5.8M

17.49%6.02M

Total assets

-12.75%261.63M

-13.49%269.58M

-14.15%278.79M

-15.09%289.64M

-15.43%299.87M

-15.30%311.63M

-14.27%324.74M

-12.65%341.14M

Liabilities

Current liabilities

Payables

-33.39%1.47M

-32.52%1.3M

-50.00%1.37M

-35.87%1.94M

-15.83%2.21M

-7.19%1.92M

44.35%2.74M

86.73%3.03M

-accounts payable

-33.39%1.47M

-32.52%1.3M

-50.00%1.37M

-35.87%1.94M

-15.83%2.21M

-7.19%1.92M

44.35%2.74M

86.73%3.03M

Current accrued expenses

-59.50%2.2M

-72.65%1.95M

-24.29%2.92M

-17.83%2.93M

21.23%5.42M

153.92%7.12M

135.95%3.85M

249.12%3.57M

Current debt and capital lease obligation

11.62%778K

11.82%757K

11.85%736K

11.88%716K

12.06%697K

12.09%677K

30.82%658K

30.88%640K

-Current capital lease obligation

11.62%778K

11.82%757K

11.85%736K

11.88%716K

12.06%697K

12.09%677K

30.82%658K

30.88%640K

Current liabilities

-40.02%7.43M

-47.30%6.39M

-21.59%7.09M

-10.71%9.62M

19.00%12.39M

64.23%12.13M

65.09%9.05M

103.98%10.78M

Non current liabilities

Long term debt and capital lease obligation

-30.85%1.74M

-27.98%1.95M

-25.57%2.14M

-23.50%2.33M

-21.65%2.52M

-20.08%2.7M

-4.45%2.88M

-2.96%3.05M

-Long term capital lease obligation

-30.85%1.74M

-27.98%1.95M

-25.57%2.14M

-23.50%2.33M

-21.65%2.52M

-20.08%2.7M

-4.45%2.88M

-2.96%3.05M

Total non current liabilities

-30.85%1.74M

-27.98%1.95M

-25.57%2.14M

-23.50%2.33M

-21.65%2.52M

-20.08%2.7M

-4.45%2.88M

-2.96%3.05M

Total liabilities

-38.47%9.18M

-43.78%8.34M

-22.55%9.24M

-13.53%11.96M

9.40%14.91M

37.76%14.84M

40.43%11.93M

64.08%13.83M

Shareholders'equity

Share capital

0.00%6K

-common stock

0.00%6K

Retained earnings

-28.82%-213.56M

-33.69%-200.52M

-45.11%-188.73M

-60.36%-177.63M

-77.45%-165.78M

-98.09%-150M

-114.19%-130.06M

-133.40%-110.76M

Paid-in capital

2.89%465.1M

2.94%461.98M

3.06%458.45M

3.13%455.25M

3.15%452.02M

3.12%448.78M

2.89%444.85M

2.70%441.42M

Gains losses not affecting retained earnings

171.24%914K

89.15%-217K

91.57%-167K

101.85%62K

66.77%-1.28M

13.61%-2M

-49.92%-1.98M

-1,275.41%-3.36M

Total stockholders'equity

-11.41%252.45M

-11.98%261.24M

-13.83%269.56M

-15.16%277.69M

-16.42%284.96M

-16.90%296.8M

-15.53%312.82M

-14.35%327.31M

Total equity

-11.41%252.45M

-11.98%261.24M

-13.83%269.56M

-15.16%277.69M

-16.42%284.96M

-16.90%296.8M

-15.53%312.82M

-14.35%327.31M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-12.67%254.07M	-13.88%261.02M	-14.17%270.69M	-14.71%281.8M	-14.71%281.8M	-15.48%290.94M	-15.66%303.09M	-15.04%315.39M	-13.98%330.39M	-13.98%330.39M
-Cash and cash equivalents	8.54%30.33M	68.03%45.7M	2.04%29.4M	-20.00%21.2M	-20.00%21.2M	-34.28%27.94M	-77.27%27.2M	-89.97%28.81M	-91.12%26.5M	-91.12%26.5M
-Short-term investments	-14.92%223.75M	-21.96%215.32M	-15.80%241.29M	-14.25%260.6M	-14.25%260.6M	-12.83%263M	15.09%275.89M	241.54%286.58M	255.44%303.89M	255.44%303.89M
Receivables	-2.40%1.18M	40.64%1.4M	72.07%1.68M	28.43%1.43M	28.43%1.43M	61.93%1.21M	43.85%994K	874.00%974K	913.64%1.12M	913.64%1.12M
-Accrued interest receivable	-2.40%1.18M	40.64%1.4M	72.07%1.68M	28.43%1.43M	28.43%1.43M	61.93%1.21M	43.85%994K	874.00%974K	913.64%1.12M	913.64%1.12M
Prepaid assets	-16.95%1.99M	23.69%2.43M	-40.77%1.52M	-62.57%1.35M	-62.57%1.35M	-31.75%2.4M	38.43%1.96M	5.49%2.57M	186.84%3.62M	186.84%3.62M
Total current assets	-12.66%257.24M	-13.46%264.84M	-14.13%273.89M	-15.08%284.58M	-15.08%284.58M	-15.48%294.54M	-15.39%306.05M	-14.69%318.94M	-13.05%335.12M	-13.05%335.12M
Non current assets
Net PPE	-19.00%3.96M	-16.14%4.31M	-16.29%4.48M	-16.73%4.63M	-16.73%4.63M	-12.93%4.89M	-10.37%5.14M	8.56%5.35M	8.53%5.56M	8.53%5.56M
-Gross PPE	-5.92%5.47M	-4.41%5.66M	-5.35%5.68M	-6.46%5.69M	-6.46%5.69M	-3.38%5.81M	-1.68%5.93M	17.09%6M	15.70%6.08M	15.70%6.08M
-Accumulated depreciation	-63.52%-1.51M	-72.58%-1.35M	-84.64%-1.2M	-102.87%-1.06M	-102.87%-1.06M	-131.41%-921K	-170.34%-784K	-230.46%-651K	-289.55%-522K	-289.55%-522K
Other non current assets	-2.29%427K	-3.38%429K	-5.53%427K	-6.32%430K	-6.32%430K	-6.22%437K	-6.33%444K	--452K	--459K	--459K
Total non current assets	-17.63%4.39M	-15.13%4.74M	-15.45%4.91M	-15.94%5.06M	-15.94%5.06M	-12.42%5.33M	-10.06%5.59M	17.73%5.8M	17.49%6.02M	17.49%6.02M
Total assets	-12.75%261.63M	-13.49%269.58M	-14.15%278.79M	-15.09%289.64M	-15.09%289.64M	-15.43%299.87M	-15.30%311.63M	-14.27%324.74M	-12.65%341.14M	-12.65%341.14M
Liabilities
Current liabilities
Payables	-33.39%1.47M	-32.52%1.3M	-50.00%1.37M	-35.87%1.94M	-35.87%1.94M	-15.83%2.21M	-7.19%1.92M	44.35%2.74M	86.73%3.03M	86.73%3.03M
-accounts payable	-33.39%1.47M	-32.52%1.3M	-50.00%1.37M	-35.87%1.94M	-35.87%1.94M	-15.83%2.21M	-7.19%1.92M	44.35%2.74M	86.73%3.03M	86.73%3.03M
Current accrued expenses	-59.50%2.2M	-72.65%1.95M	-24.29%2.92M	-17.83%2.93M	-17.83%2.93M	21.23%5.42M	153.92%7.12M	135.95%3.85M	249.12%3.57M	249.12%3.57M
Current debt and capital lease obligation	11.62%778K	11.82%757K	11.85%736K	11.88%716K	11.88%716K	12.06%697K	12.09%677K	30.82%658K	30.88%640K	30.88%640K
-Current capital lease obligation	11.62%778K	11.82%757K	11.85%736K	11.88%716K	11.88%716K	12.06%697K	12.09%677K	30.82%658K	30.88%640K	30.88%640K
Current liabilities	-40.02%7.43M	-47.30%6.39M	-21.59%7.09M	-10.71%9.62M	-10.71%9.62M	19.00%12.39M	64.23%12.13M	65.09%9.05M	103.98%10.78M	103.98%10.78M
Non current liabilities
Long term debt and capital lease obligation	-30.85%1.74M	-27.98%1.95M	-25.57%2.14M	-23.50%2.33M	-23.50%2.33M	-21.65%2.52M	-20.08%2.7M	-4.45%2.88M	-2.96%3.05M	-2.96%3.05M
-Long term capital lease obligation	-30.85%1.74M	-27.98%1.95M	-25.57%2.14M	-23.50%2.33M	-23.50%2.33M	-21.65%2.52M	-20.08%2.7M	-4.45%2.88M	-2.96%3.05M	-2.96%3.05M
Total non current liabilities	-30.85%1.74M	-27.98%1.95M	-25.57%2.14M	-23.50%2.33M	-23.50%2.33M	-21.65%2.52M	-20.08%2.7M	-4.45%2.88M	-2.96%3.05M	-2.96%3.05M
Total liabilities	-38.47%9.18M	-43.78%8.34M	-22.55%9.24M	-13.53%11.96M	-13.53%11.96M	9.40%14.91M	37.76%14.84M	40.43%11.93M	64.08%13.83M	64.08%13.83M
Shareholders'equity
Share capital	0.00%6K	0.00%6K	0.00%6K	0.00%6K	0.00%6K	0.00%6K	0.00%6K	0.00%6K	0.00%6K	0.00%6K
-common stock	0.00%6K	0.00%6K	0.00%6K	0.00%6K	0.00%6K	0.00%6K	0.00%6K	0.00%6K	0.00%6K	0.00%6K
Retained earnings	-28.82%-213.56M	-33.69%-200.52M	-45.11%-188.73M	-60.36%-177.63M	-60.36%-177.63M	-77.45%-165.78M	-98.09%-150M	-114.19%-130.06M	-133.40%-110.76M	-133.40%-110.76M
Paid-in capital	2.89%465.1M	2.94%461.98M	3.06%458.45M	3.13%455.25M	3.13%455.25M	3.15%452.02M	3.12%448.78M	2.89%444.85M	2.70%441.42M	2.70%441.42M
Gains losses not affecting retained earnings	171.24%914K	89.15%-217K	91.57%-167K	101.85%62K	101.85%62K	66.77%-1.28M	13.61%-2M	-49.92%-1.98M	-1,275.41%-3.36M	-1,275.41%-3.36M
Total stockholders'equity	-11.41%252.45M	-11.98%261.24M	-13.83%269.56M	-15.16%277.69M	-15.16%277.69M	-16.42%284.96M	-16.90%296.8M	-15.53%312.82M	-14.35%327.31M	-14.35%327.31M
Total equity	-11.41%252.45M	-11.98%261.24M	-13.83%269.56M	-15.16%277.69M	-15.16%277.69M	-16.42%284.96M	-16.90%296.8M	-15.53%312.82M	-14.35%327.31M	-14.35%327.31M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Trending US Stocks

Symbol Mini Chart % Chg

Collegium Pharmaceutical

Unlock the Full List